Patents by Inventor Patrick Michael Reeves

Patrick Michael Reeves has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8765777
    Abstract: Compositions and methods are provided for using tyrosine kinase inhibitors to treat pathogenic infection. In particular, methods for using Abl-family tyrosine kinase inhibitors to treat pathogenic infection are provided. Infections to be treated according to the present invention include, particularly, those caused by microbial pathogens such as bacteria and viruses.
    Type: Grant
    Filed: December 16, 2010
    Date of Patent: July 1, 2014
    Assignees: Emory University, Sloan Kettering Institute for Cancer Research
    Inventors: Daniel Kalman, William Gerard Bornmann, Patrick Michael Reeves, Alyson Irene Swimm
  • Publication number: 20110281867
    Abstract: Compositions and methods are provided for using tyrosine kinase inhibitors to treat pathogenic infection. In particular, methods for using Abl-family tyrosine kinase inhibitors to treat pathogenic infection are provided. Infections to be treated according to the present invention include, particularly, those caused by microbial pathogens such as bacteria and viruses.
    Type: Application
    Filed: December 16, 2010
    Publication date: November 17, 2011
    Inventors: Daniel KALMAN, William Gerard Bornmann, Patrick Michael Reeves, Alyson Irene Swimm